Nordhealth (NORDH) Stock Overview
Provides healthcare software solutions in Norway, Finland, Sweden, the United Kingdom, Denmark, DACH, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
NORDH Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Nordhealth AS Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NOK 24.60 |
| 52 Week High | NOK 40.40 |
| 52 Week Low | NOK 21.20 |
| Beta | 0.35 |
| 1 Month Change | -1.60% |
| 3 Month Change | -15.17% |
| 1 Year Change | -39.11% |
| 3 Year Change | 6.96% |
| 5 Year Change | -42.82% |
| Change since IPO | -33.51% |
Recent News & Updates
Recent updates
Shareholder Returns
| NORDH | NO Healthcare Services | NO Market | |
|---|---|---|---|
| 7D | -9.6% | 2.3% | -0.9% |
| 1Y | -39.1% | -11.8% | 17.7% |
Return vs Industry: NORDH underperformed the Norwegian Healthcare Services industry which returned -13.2% over the past year.
Return vs Market: NORDH underperformed the Norwegian Market which returned 18.3% over the past year.
Price Volatility
| NORDH volatility | |
|---|---|
| NORDH Average Weekly Movement | 10.8% |
| Healthcare Services Industry Average Movement | 6.3% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in NO Market | 11.6% |
| 10% least volatile stocks in NO Market | 3.1% |
Stable Share Price: NORDH's share price has been volatile over the past 3 months compared to the Norwegian market.
Volatility Over Time: NORDH's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Norwegian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 457 | Charles MacBain | nordhealth.com |
Nordhealth AS provides healthcare software solutions in Norway, Finland, Sweden, the United Kingdom, Denmark, DACH, and internationally. Its products include Provet, a practice management software platform for veterinary clinics and enterprise groups, providing appointment scheduling, patient management, electronic health records, billing and invoicing, reporting and analytics, government compliance tools, communication features, inventory management, and workflow automation; Diarium, a PMS for therapists that streamlines therapy sessions, booking, and invoicing; Physica, a PMS for physiotherapists; Psykbase, a PMS for psychologists and psychiatrists; EasyPractice, a PMS for therapists; and various PMS for veterinarians under the Vetserve, Sanimalis, Vetvision, and Vetera names. The company’s products comprise Nordhealth Connect, a communication platform for patients and healthcare professionals; and Navisec, a digital learning environment for training and orientation.
Nordhealth AS Fundamentals Summary
| NORDH fundamental statistics | |
|---|---|
| Market cap | NOK 1.94b |
| Earnings (TTM) | -NOK 165.55m |
| Revenue (TTM) | NOK 564.29m |
Is NORDH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NORDH income statement (TTM) | |
|---|---|
| Revenue | €51.83m |
| Cost of Revenue | €39.43m |
| Gross Profit | €12.40m |
| Other Expenses | €27.60m |
| Earnings | -€15.20m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
Aug 18, 2026
| Earnings per share (EPS) | -0.19 |
| Gross Margin | 23.92% |
| Net Profit Margin | -29.34% |
| Debt/Equity Ratio | 0% |
How did NORDH perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/08 12:04 |
| End of Day Share Price | 2026/06/08 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Nordhealth AS is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kristian Støle | Carnegie Investment Bank AB |
| Eirik Rafdal | DNB Carnegie |